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Abstract
The clinical application of Functional Electrical Stimulation (FES) has evolved over the last five decades.
However, the use of the Randomized Control Trial (RCT) methodology in evaluating the clinical effectiveness of new
and existing applications of FES is a demanding process adding time and cost to these trials. Consequently, there
has been a low level of RCTs applied to FES studies. Poor quality trials result in poor evidence of FES effectiveness
with a consequence that the technique may not be adopted into clinical practice. In this paper some of the key
challenges encountered in FES randomised control clinical trials are identified and a solution to address these
challenges is presented in the form of a smartphone App and a Bluetooth controlled FES architecture. The design
and evaluation of a smartphone application using a User Centred Design approach to provide automatic blind
randomization control and facilitating the wireless temporal control of a portable Bluetooth enabled FES device is
described.
Introduction
Functional electrical stimulation
Functional Electrical Stimulation (FES) is the application of
Neuromuscular Electrical Stimulation (NMES) in real-time (typically
under sensor control) to contract a muscle to perform a functional
task. FES technology has advanced significantly, particularly in the last
two decades. New applications and new approaches to existing
applications of FES are being continually investigated to find improved
treatments for patients with a variety of clinical pathologies [1-3]. To
establish the effectiveness of any new FES application or of a new
approach to an existing application of FES, it must be evaluated using a
robust clinical investigation.
Randomized control trials
A key requirement of an effective clinical investigation is an
experimental methodology that features (i) unbiased randomization
into at least two comparable groups, (ii) blinded assessment by
clinicians and ideally (iii) blinding of the participants to their
intervention allocation. The most commonly used and robust clinical
investigation design is the Randomized Controlled Trial (RCT). A well
conducted RCT is regarded as the gold standard method for evaluating
the efficacy or / and effectiveness of a health or medical treatment [4].
Although, performing a RCT effectively adds time and cost to a clinical
investigation [5], failure to not adequately adhere to this methodology
can result in poor clinical evidence being generated. Without robust
evidence being generated through clinical evaluation, technical
advances are unlikely to be adopted into routine clinical practice. Thus
providing strong clinical evidence is essential so patients are not
deprived access to potentially new medical treatments that could
positively impact on their lives.
Implementing RCTs
Step 1 Randomization sequencing: The first step in implementing an
effective RCT requires the randomization sequencing of treatments.
Randomization sequencing aims to blind trial organisers and
participants to the sequence of allocated intervention treatments.
Treatment allocation can be performed easily by assigning each
treatment randomly [6,7]. A number of websites and desktop
programs are capable of providing either random number tables or
random number generators running locally on a PC or hosted by an
Internet server [8]. However, as identified by Saghaei et al. most of the
internet services have limited capabilities with respect to the block
design specification and control over the output format [8]. These
services can provide randomization sequencing but they fail in the
ability to provide treatment allocation concealment and assignment.
Step 2 Allocation concealment and assignment: Allocation
concealment and assignment is the second step in implementing an
effective RCT. Methods used to implement allocation concealment and
assignment commonly use a central telephone randomization system
and numbered containers [9,10]. Traditionally, sequentially numbered,
opaque sealed envelopes (SNOSE) have been the method for
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concealment, particularly in resource-poor settings [10]. Using the
SNOSE method [11], treatments are randomly concealed within
opaque sealed envelopes and sequentially assigned to participants as
they enrol in the trial. However, this method has been shown to be
prone to tampering [9,12]. Treatment allocations may be revealed if
envelopes are held up to a bright light or envelopes may be opened in
advance of participant enrolment. As a result, some reviewers treat
trials using envelopes as a means of allocation concealment with
caution [13-15]. Alternatively, scratch card technology has been
recently adopted. Research staff who had previously used the SNOSE
system for random allocation reported the scratch card technology
easier to use [16]. To date the use of scratch card technology is limited
and may be due to the limited number of companies equipped to
develop the technology. The use of a central systems such as 24 h
central randomization office (telephone or web-based) offer a high
level of security, with stringent procedures and trained staff members
[9]. Central systems ensure allocation concealment by independently
assigning treatments and withholding assignment information from
research staff until all participants are assigned. Armijo-Olivo et al.
showed that from 2005 to 2011, 18.9% of the included trials used
central randomization, 21.6% used SNOSE, and 13.5% used unsafe
envelopes and 46% used non-safe methods of allocation concealment
[17]. In a review of RCT published in 2011, Clark et al. [18]
highlighted that, 15% of the included trials used central randomization
while 31% used envelopes as a method of allocation concealment. In
contrast, Chen et al. [19] reported that between 2011 to 2013 the
number of trials using central randomization / pharmacy surpassed
that of sealed envelopes.
Step 3 Allocation of assigned intervention: Following allocation
concealment and assignment, a member of the research staff allocates
the assigned intervention treatment. Intervention allocation is the
third step in implementing an effective RCT and is performed by an
investigator which is typically an independent doctor, clinician or
researcher. Intervention allocation is highly dependent on the design of
each trial. Typical, during an investigator blinded RCT with a SNOSE
method of assignment, a member of the research staff would open the
participant’s assigned envelope and provide the investigator with the
assigned intervention. Alternatively, if a central randomization method
of assignment is used, a member of the research staff would receive a
participant’s treatment from the central randomization provider via
telephone, email or fax, and provide the investigator with the assigned
intervention. To ensure the investigator cannot decipher the assigned
intervention treatment, treatments are typical undisguisable from each
other. During a double blind RCT, the participant and investigator is
unaware of the intervention received although this is not possible in all
cases due to the type of treatment. In general the implementation of an
RCT varies between medical disciplines due to the different types of
intervention and trial methodologies. The techniques used to provide
randomization, allocation concealment assignment and intervention
allocation are adjusted to each trial needs with the aim.
Functional electrical stimulation trial methodologies
Designing a protocol for an RCT using an FES device is particularly
challenging as there is a wide range of parameters that can be adjusted
in any FES treatment (Figure 2): pulse width, inter-pulse interval, pulse
frequency, ramp-up time, ramp-down time, ON-time and OFF-time
and different stimulus intensity envelope shapes. An FES trial may
want to assess the impact of changing these parameters using a variety
of permutations and combinations. For example, over the period
2014-2015, in a search of the PubMed, Scopus, Science Direct and
Google Scholar databases, 23 studies were identified where FES
protocols were investigated with multiple FES treatments. All
publications reported using randomization but only 1 publication
reported the method of randomization. De et al. reported each
treatment was randomly chosen for each participant using
Randomizer v4.0 software [20]. Four publications reported using
single blinding and two used double blinding. Within the reported
double blinded studies, Dantas et al. [21] reported the blinding of both
investigator and participant to the treatment being applied, but did not
specify how this was achieved and Scot et al. [22] reported the blinding
of both observer (individual who viewed the treatment effects) and
participant to the treatment being applied, but again did not specify
how this was achieved. None of the papers identified referred to
implementing allocation concealment and assignment.
Figure 1: General RCT randomization procedure: (a) without third
party services (i.e., SNOSE) (b) with third party services (i.e.,
Central randomisation office).
Although the above identified studies report using randomization
they lack the methodological requirements for an RCT, and as such
only one identified study classified itself as an RTC [21]. It is clear that
the implementation of an RCT methodology (Figure 1) is very
demanding as it involves both extensive time and cost to the trial. A
high level of discipline and adherence to the protocol is required from
the research staff. Extensive manual data collection and handling
requires strict quality assurance and control. An additional challenge
in FES trials is the need to manually configure the FES device for each
participant, prior to their treatment; this is highly time consuming and
is prone to error. The manually configuration effectively eliminates
blinding during the intervention allocation process unless the manual
adjustments are achieved through an independent investigator.
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Figure 2: Common adjustable FES treatment parameters.
In a randomized sham control study of direct current stimulation,
Wu et al. streamlined the manual configuration of their stimulation
device, by programming the device to automatically generate an active
or sham device state according to the parity of a random number. The
random number generated was inputted into the device by an
independent investigator [23]. In another trial Szecsi et al. [24] enabled
the configuration of a stimulation device through a physical switch
which selected between two pre-programmed stimulation treatments
[25]. While these approaches reduced the time to configure the
stimulation devices by loading pre-configured treatments, they still
required an independent investigator to configure the device to match
the participant’s allocated treatment.
An additional developing challenge in FES trials is the temporal
(on-the-fly) control of stimulus. For participant-worn FES devices the
manual temporal control of stimulus delivery by the clinician in real-
time can be difficult. Manual temporal control typically requires a
wired connection from a clinician control switch to a sensor / control
input on the stimulator device, if it is available. To date temporal
control of FES is typical achieved through tethered FES systems
[26,27]. The usability of such tethered FES systems in clinical settings
can be an undesirable factor influencing the trial’s outcome. The
temporal control of an FES treatment by the clinician, while the
participant is, for example, walking, is highly cumbersome.
The work presented in this paper is focused on addressing these
identified challenges associated with using FES in clinical trials. We
propose a solution to address these challenges through the adoption of
smartphone technology. The design of a smartphone application
providing automatic blind randomization control functionality and
facilitating the wireless temporal control of a portable Bluetooth
enabled FES device is described.
Methods
Design requirements
In order to design an effective smartphone App in conjunction with
a Bluetooth-enabled portable FES device, certain specific design
requirements were required to be met. These requirements were
identified in response to the identified challenges in using FES in
clinical trials. Primarily it was required to meet the core functional
requirement for treatment randomization and temporal wireless
control and also it was required to provide a good user experience for
clinicians and researchers. Ethical approval to test the system was
granted by University Hospital Galway research ethics committee.
Blind randomization control requirements
Developing an App that has the ability to transparently provide
treatment allocation concealment, randomization and blind allocation
assignment was a key design challenge. The App was required to
facilitate the evaluation of repeated measures (within participant)
RCTs. The FES parameters; Stimulus Intensity, Frequency, ON / OFF
time, and Ramp-up / down time formed the parameters of treatment.
To allow the generation of treatments, a GUI was necessary to enable
adjustment of FES parameter values. A key system requirement was the
use of robust randomization technique, as insufficient randomization
could produce biased results, which would compromise the reliability
of the App. Additionally, to control possible treatment order effects,
treatment order balancing was required. Blinding of both the
participant and the clinician from the selected treatment required the
automatic configuration of the FES device stimulus parameters. To
enable data analysis, all treatment parameters and participant data
were required to be logged on the smartphone.
Wireless temporal stimulator control requirements
Wireless Temporal Stimulator Control allows the wireless control of
a Bluetooth1 enabled FES device in real-time. Currently the IEEE
11073 Personal Health standard, which addresses the interoperability
of personal health devices, has no device specialization standard for
FES devices. As such a specific Bluetooth proprietary communication
protocol was required, which incorporated a precise design to ensure a
reliable protocol with low latency. To facilitate the adjustment of the
FES device parameters by a clinician, including the control of
treatment delivery, a custom GUI was designed. Additionally,
safeguards were required to eliminate malicious or accidental user
misuse. Such safeguards were incorporated through tactile and visual
feedback during critical operations. Additionally, it was critical that
unauthorized receivers cannot intercept any wirelessly transmitted
data, which could promote tampering. To allow the safe delivery of a
controlled stimulus treatment, delivery was required to be
implemented in a manner that only permits delivery under the direct
control of the clinician.
Usability requirements
The proposed App was intended for research use by clinicians and
researchers assessing FES treatment strategies. To achieve this, the App
interface was required to be ergonomic in design, allowing young and
older users to operate the App without difficulty. For small-screen
devices where the user’s attention is at a premium, the efficiency by
which the user can adjust the control settings was an extremely
important design consideration [28]. To reduce the complexity of the
interface the user was often only required to access a minimum control
set. Therefore, it was proposed that the interface should be kept both
narrow (minimum choice on screen) and shallow (minimum screen
hierarchy levels) enabling the users to complete actions as quickly as
possible.
1 Bluetooth SIG Inc., 5209 Lake Washington Blvd NE, Suite 350, Kirkland, WA 98033, USA.
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System Overview
The system consisted of a smartphone, a mobile App and a
Bluetooth compatible FES device. The architecture of the purposed
system is presented in Figure 3 which highlights the main components
of the system. The Motorola Moto G smartphone manufactured by
MotorolaTM was selected as the system smartphone. The Moto G
provides useful features for the application such as a 4.5” LCD touch
screen, Bluetooth low energy (BLE) connectivity, internal 16 GB
storage and Google AndroidTM 4.3 Operating System (OS) pre-
installed. Android OS is an open source platform offering a high level
of software control over its device features, permitting this
commercially available device to be used as a research tool.
The App, developed in Java2, for the Android OS platform,
implemented Android’s Application Program Interface (API) to
employ the smartphones built-in functions and functionality. The App
was developed for 4.3 or later Android OS, which supported the BLE
network and was tested and debugged using Android StudioTM
version 0.8.62.
The FES device utilized for the system was a research device
designed in-house at NUI Galway. BLE wireless technology was
incorporated into the FES design to facilitate the wireless control and
optimization of stimulation parameters. The FES device Bluetooth
GATT profile established common operations and a framework for
data transmission, defining the attribute protocol for discovering
services, and reading/writing characteristic values on the FES device
GATT server.
Blinded randomized control overview
The blind randomization control requirements were such that the
clinician could manually generate FES treatments, based on the
selection of treatment parameter values. Adjustment values ranged
from Stimulus Intensity (0% - 100% in increments of 1%), Frequency
(30 Hz - 40 Hz in increments of 1 Hz), ON / OFF time (0 s – 2 s in
increments of 0.2 s) and Ramp – up / down time (0 s – 2 s in
increments of 0.2 s). A maximum of 100 treatments could be created
by saving multiple treatments in an Android “List” class. Each new
treatment entered was added to the Treatment List “Tn+1”, where n is
the number of treatments in the list, Figure 4.
Upon completion of the Treatment List the clinician selects the
number of participants, “P”. To ensure that the generated order of
treatments are sequenced in a counterbalanced fashion (a balanced
Latin Square [29] was implemented). To implement a balanced Latin
Square protocol, the number of participants “P” enrolled must be a
multiple of the number of treatments Tn generated, therefore P = n ×m, where m is a multiplier. The balanced Latin square was
implemented using an array “L” of size n × n, with elements l (i,j)
representing a treatment Tn, in which (l (i,j), l (i, j+1)) elements pairs
were all distinct. To facilitate the selection of multiple participants and
treatment blocks “b”, L was duplicated “m × b” times resulting in a
Treatment Array “TA” of size (n × m) × (n × b), Figure 5.
Figure 3: Proposed system architecture.
Each row “i” of matrix TA represented a Treatment Order “TOi”,
which can be allocated to a participant. Loading TOi into a list and
implementing the Android shuffle class, based on Fisher and Yetas
algorithm [30], allowed the rows of TA to be shuffled randomly,
generating a random distribution of Treatment Orders. Figure 6
illustrate the generation of a random distribution of Treatment Orders
for an RCT with four Treatments and the enrolment of eight
participants with two treatment blocks.
Blind allocation of the treatment orders was achieved through
Androids built-in BLE API, permitting the wireless configuration of
the FES device for each participant, prior to the delivery of their
treatment. During the allocation process the App automatically
assigned the participants sequentially with the rows “i” of the
Treatment Array, Pi ta (i, j), Figure 7. Treatment Allocations were
stored in the internal memory of the smartphone and only become
visible to the clinician after the trial was completed, eliminating
possible biasing during testing.
Figure 4: Treatment list structure.
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Figure 5: Treatment array structure (Unshuffled).
Figure 6: Treatment order randomization example, n = 4, P = 8 , m
= 2, b = 2.
Figure 7: Participant treatment allocation. P8 (participant eight) is
allocated treatment order number 8 (row eight of the treatment
array). P1 (participant one) is allocated treatment order number 1
(row one of the treatment array).
Wireless temporal stimulator control overview
Wireless temporal control provided the capability for on-the-fly FES
parameter adjustment and FES treatment delivery control via the App.
The BLE specification uses a client-server architecture, which enables
the communication of packets using a synchronous request-response
messaging pattern. This protocol ensured synchronization between the
App and the FES device, with all transmitted request packets requiring
the receipt of a response packet. Failure to receive a response within
the time-out period resulted in the re-transmission of the request until
a response was acknowledged. To ensure all transmitted data remain
secure, an encryption, authentication and authorization security
protocol inherits to Bluetooth was implemented. The implemented
wireless temporal control enabled the clinician to: Progress through a
participant’s Treatment Order and transparently uploading treatments
to the FES device.
Deliver treatments by pressing a single tactile on-screen button,
which when pressed started a treatment and which upon release
stopped the treatment.
During FES value adjustments safeguards are employed to check
and verify new values were within the prescription range of the FES
parameters for the patient. In the event of an invalid value the clinician
was alerted by popup message on the smartphone. An automatic
logging feature allowed adjustments and treatment delivery activities
to be stored on the internal memory storage of the smartphone.
Usability overview
The App implemented four activity classes. The classes were coded
to perform two main system functions, (i) blind randomization control
and (ii) wireless temporal stimulator control. Each activity was
associated with a unique GUI, Figure 8. Activities were coded to
handle clinician input through Android’s standard Spinner’s, Edit
Text’s and Buttons classes. The App consists of only two hierarchy
levels. In the initial hierarchy level the user was presented with the
main menu GUI, which provided the choice of three options to
advance to the next hierarchy level, Figure 9. The second hierarchy
level enabled the user to generate treatments, allocate treatments and
control treatment delivery through individual GUIs, Figure 8.
Figure 8: App activity design.
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Figure 9: App screenshot of main menu.
Figure 10: App Screenshot of: (a) Treatment generation GUI, (b)
Treatment allocation GUI, (c) Treatment delivery GUI.
Evaluation Methodology
Blinded randomized control
The goal of the Blinded Randomized Control evaluation was to
determine whether the randomization process could be implemented
successfully within a smartphone application, and to assess its
implemented features to ensure reliability. Evaluation was performed
using statistical tools to assess if randomization was successfully
achieved. The “runs test” [31] and the normal probability plot were
performed using Matlab. The runs test (Wald–Wolfowitz test) is a
nonparametric statistical test that checks the null hypothesis that a
series of data are generated randomly Figure 10. Normal probability
plots assess if data arise from a normal distribution. The process
involved the simulation of an RCT with six treatments, six participants
and one treatment block. The simulation was performed 7200, 72,000,
720,000 times and evaluation of the resulting series of Treatment
Arrays with the “runs test” was performed. The normal probability plot
assessed the frequency occurrence of each of the resulting series of
Treatment Arrays.
Wireless temporal stimulator control
The goal of the Wireless Temporal Stimulator Control evaluation
was to determine the reliability and performance of the App’s
communication protocol. The latency time associated with the round
trip write request of an attribute protocol message was assessed, Figure
11. The data were processed using Matlab4 to plot the latency
distribution. Evaluation was performed by measuring the time
between the App (client) writing a remote FES configuration attribute
on the FES device GATT server and the receipt of a write
acknowledgement on the App. A total of 1501 Write operations were
performed through the App and the latency was measured, with the
BLE connection between the App and FES device pre-established. The
evaluation was performed twice at Received signal strength (RSSI) of ~
-75 dB and ~ -95 dB.
Figure 11: Request to response latency timing diagram.
Usability
The App was developed using an iterative User Centred Design
approach as presented by Harte et al. Development of the App was
carried out using an agile approach, with each iteration of the App
tested on the target user population and detailed feedback sought in
each case. Following feedback, changes were made to the App and the
process repeated until an App with good user acceptance was achieved.
Results
Simulations of RCT Treatment generation and allocation were
conducted using the App to evaluate the functionality and reliability of
the processes. The maximum setting of 100 generated treatments and
1000 participants with 10 blocks of treatments was simulated; the
average time to generate and store the Treatment Array and Treatment
List was ~ 28 s.
Figure 12 shows the cumulative distribution of the latency time
between the App writing a remote FES configuration attribute on the
FES device GATT server and the receipt of a write acknowledgement
by the App. At an RSSI of -75 dB the latency time was < 15 ms for 78%
and < 20 ms for 97% of the 1501 write operations. At an RSSI of -95 dB
the latency time was < 15 ms for 56% and < 20 ms for 93% of the 1501
write operations. The longest time for a response was 34 ms and in all
cases zero packets were lost.
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The results from the normal probability plot are presented in Figure
13. The x-axis data represent the distribution of the 720,000 generated
Treatment Array frequencies. From observation of the normal
probability plot it is evident that the processed data exhibit the
standard "bell curve" or Gaussian distribution centered on a frequency
of 1000.
The results from the runs test with a significance level of 0.05 are
given in Table 1 and support the hypothesis that the series of generated
Treatment Arrays are in a random order
Figure 12: Latency time cumulative distribution plot.
Figure 13: Randomization probability plot.
Runs Test
Results
Sequence Length
7200 720000 720000
P - value 0.6253 0.6789 0.5704
Null hypothesis True True True
Table 1: Runs test results for 7200, 72000.
Conclusion
In this paper, a smartphone App for the control of an FES device,
which addresses some of the current challenges associated with the use
of FES in research and clinical trial settings was presented. The App
was designed to meet the requirements of clinicians and researchers
working in the area of FES. The Apps demonstrates a capability to
perform such functions as Treatment Generation, Allocation
Concealment, Allocation Randomization, Blind Allocation
Assignment, FES Device Configuration and electronic data logging.
The App would thus serve to significantly streamline the
implementation of FES RCTs by reducing extensive manual data
collection, reducing the research staff required, removing the necessity
for assistance of any third party during treatment allocation (Figure
14) and providing on-the-fly FES parameter adjustment. Results from
the evaluation show good reliability and performance thereby
supporting the implementation of blinded randomized control and
temporal control of an FES device through a smartphone application.
It is anticipated that the use of smartphone technology, Bluetooth
enable FES devices and the development of Apps will aid in the design
of effective RCTs of FES systems by providing a portable and flexible
platform that will reduce costs and increase the robustness and
efficiency of these studies. The costs associated with developing
smartphone applications for research purposes can be relatively low,
with Android providing an open source platform for development and
Apple requiring a yearly fee of $99 to develop Apps for the Apple
platform. For researchers with App development experience the
majority of the costs are associated with the development time
required to customize the App to meet the specific trial methodology
requirements and to develop the Bluetooth communication protocol.
As there is no specialized standard for FES devices within the IEEE
111073 Personal Health standard repository, in this study an in-house
FES device was used with a proprietary GATT profile communication
protocol. The development of a standard GATT profile for FES devices
may enable greater interoperability among Bluetooth enabled FES
devices and smartphone applications.
In addition to considering the cost of developing the App, concerns
over usability and security may affect the acceptance of the technology.
Researchers considering the development and use of similar Apps
should consult with clinicians throughout the development stages to
identify potential issues such as button size and interface layout. In this
work the clinical team recommended, large buttons with tactile
feedback be adopted and these features are embedded in the developed
App.
Although our App demonstrated the ability to support the
implementation of blind randomized control and temporal control of
an FES device we acknowledge it is only developed for a single site
trial. Further work may consider the development of a multi-site trial
randomization App. Although such implementations will add
additional cost to the App development and require additional security
and infrastructure cost through the use of server and network provider
resources, they may provide a cost effective alternative to existing
methods of multi-site trial randomization services.
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Figure 14: General RCT randomization procedure: (a) Without
third party services, (b) With third party services, (c) Utilizing the
randomisation App.
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